Investing.com - Financial Markets Worldwide

Oneness Biotech Co Ltd (4743)

TPEX
Currency in TWD
68.10
-0.80(-1.16%)
Closed·
4743 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Earnings results expected tomorrow
4743 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
68.1075.50
52 wk Range
51.40164.00
Key Statistics
Edit
Bid/Ask
220.50 / 221.00
Prev. Close
64.7
Open
75.5
Day's Range
68.1-75.5
52 wk Range
51.4-164
Volume
14.62M
Average Volume (3m)
3.81M
1-Year Change
-48%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4743 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
308.00
Upside
+352.28%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Analysts anticipate sales growth in the current year
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Oneness Biotech Co Ltd Company Profile

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan. It offers Fespixon cream for diabetic foot ulcers. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis; OB318, an anticancer botanical drug of antrodia cinnamomea; SNS812, for the treatment of COVID-19 that is in Phase II clinical trials; and SNS851 for weight loss and metabolism diseases. In addition, the company engages in the management of agriculture cultivation and trading business; and production and sale of agricultural products. Oneness Biotech Co., Ltd. was incorporated in 2008 and is headquartered in Taipei, Taiwan.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
43
Market
Taiwan

Compare 4743 to Peers and Sector

Metrics to compare
4743
Peers
Sector
Relationship
P/E Ratio
−26.4x−14.3x−0.5x
PEG Ratio
3.340.110.00
Price/Book
2.8x2.1x2.6x
Price / LTM Sales
277.6x5.3x3.3x
Upside (Analyst Target)
347.0%0.0%43.5%
Fair Value Upside
Unlock−5.4%6.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 308.00
(+352.28% Upside)

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.34 / -0.49
Revenue / Forecast
25.22M / 28.00M
EPS Revisions
a
a
Unlock
Last 90 days

4743 Income Statement

FAQ

What Stock Exchange Does Oneness Biotech Trade On?

Oneness Biotech is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Oneness Biotech?

The stock symbol for Oneness Biotech is "4743."

What Is the Oneness Biotech Market Cap?

As of today, Oneness Biotech market cap is 31.42B.

What Is Oneness Biotech's Earnings Per Share (TTM)?

The Oneness Biotech EPS (TTM) is -2.58.

When Is the Next Oneness Biotech Earnings Date?

Oneness Biotech will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is 4743 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Oneness Biotech Stock Split?

Oneness Biotech has split 8 times.

How Many Employees Does Oneness Biotech Have?

Oneness Biotech has 43 employees.

What is the current trading status of Oneness Biotech (4743)?

As of 07 Aug 2025, Oneness Biotech (4743) is trading at a price of 68.10, with a previous close of 64.70. The stock has fluctuated within a day range of 68.10 to 75.50, while its 52-week range spans from 51.40 to 164.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.